Complementary structural investigation of intrinsically disordered protein tau, involved in neurodegenerative diseases

 O. Cehlar1, R. Skrabana1,2, Z. Flachbartova1, M. Novak1,2

aInstitute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, 845 10 Bratislava, Slovakia

bAxon Neuroscience GmbH, Rennweg 95/b, A-1030 Vienna, Austria

 

Microtubule-associated intrinsically disordered protein tau has under physiological conditions very flexible molecule, similar to the random coil [1]. When interacting with microtubules, the proline-rich and repeat regions of tau molecule play the most prominent role [2]. In the course of neurodegenerative tauopathy (e.g. Alzheimer’s disease), tau undergoes numerous posttranslational modifications, dissociates from microtubules and forms highly compact, insoluble paired helical filaments (PHF) [3]. Interestingly, microtubule-interacting sequences on tau constitute the core of the PHF [4].

In our work, the thermodynamics and structure of microtubule binding motifs of tau have been studied with the use of monoclonal antibodies as surrogate tau protein binding partners. Surface plasmon resonance was used to monitor the binding of monoclonal antibody Fab fragment to full length and truncated tau proteins. Thermodynamic analysis showed that specific truncation of tau protein molecule, which was observed under disease conditions [5, 6], results in substantial alteration of tau binding to antibody, pointing to higher accessibility of microtubule binding sequences in truncated tau proteins. To make an insight into structure of tau complexes, Fab fragments have been crystallized alone and with tau peptides. We report preliminary X-ray diffraction analysis of three crystal types diffracting up to 1.72 Å.

Acknowledgement. This work was supported by the Slovak Research and Development Agency under the contracts Nos. LPP-0038-09 and by the Slovak Grant Agency VEGA grants Nos. 2/0162/10, 2/0217/10.

1.     Dyson HJ & Wright PE (2005) Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6, 197-208.

2.     Mukrasch MD, Bibow S, Korukottu J, Jeganathan S, Biernat J, Griesinger C, Mandelkow E & Zweckstetter M (2009) Structural polymorphism of 441-residue tau at single residue resolution. PLoS biology 7, e34.

3.     Goedert M & Jakes R (2005) Mutations causing neurodegenerative tauopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1739, 240.

4.     Novak M, Kabat J & Wischik CM (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. The EMBO journal 12, 365-370.

5.     Wischik CM, Novak M, Thogersen HC, Edwards PC, Runswick MJ, Jakes R, Walker JE, Milstein C, Roth M & Klug A (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 85, 4506-4510.

6.     Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, Rolkova G, Kontsekova E & Novak M (2006) Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. febs letters 580, 3582-3588.